Medicago receives 2009 Genesis Innovation Award
"We are pleased to have received yet another industry award which highlights our innovation behind the utilization of plants and VLPs for the production of vaccines," said Andy Sheldon, President and CEO of Medicago. "As we transition to a clinical company this year, we are proud that our mission to develop highly effective vaccines, rapidly and cost effectively, has been recognised through this award."
Most read news
Other news from the department business & finance
Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.